Should Colchicine Become Standard Therapy for CAD?

Collaborative CME and Research Network

P. Ridker

MR Quantification: Guideline Gaps

Piedmont's Marcus Heart Valve Center

The History of Invasive Cardiac Procedures

Joel Gorfinkel

Cardiology’s Biggest Controversy: The Lumen or the Wall - the Curiou…

Cedars Sinai

J. Forrester

CRT 2025 Insights: Artificial Intelligence Based System for Identify…

CRT 2025 Insights

Y. Feld

Hemodynamic vs. Hemo-Metabolic Shock: Redefining Shock Profiles

The Cardiogenic Shock Working Group

N. Kapur

The History of Invasive Cardiac Procedures - Updated

Joel Gorfinkel

Contemporary Management of Cardiogenic Shock: Updates in 2022

Mount Sinai Advanced Innovations in Heart Failure

D. Baran

Emotional Toll of Complications

The Christ Hospital Heart & Vascular Institute

W. Lombardi

Peripheral Vein Cannulation Using Ultrasound: Should You Choose the …

Venous Edge

W. Marston, H. Gajraj

CT FFR Is Already the Gold Standard for Ischemia Evaluation. Here Is…

Controversies in Interventional Cardiovascular Therapies - CICT 2024

K. Al-Azizi

ESC 2024 Insights: State-of-the-Art Lecture on Calcium Modification:…

ESC 2024 Insights

A. Kini

Is FFR Dead? Addressing Contrarian FFR Studies

Scottsdale Interventional Forum 2023

M. Kern

Congestive Heart Failure: Symptoms, Stages and Treatment: Relieve Me…

Scottsdale Interventional Forum 2024

S. Schmaltz

Catheters, Guidewires, and Other Devices to Achieve Technical Succes…

Jaikirshan Khatri

Co-Registration: Do We Really Need It? - 2025 Update

ARCH Advanced Revascularization Symposium

P. Thakker

Cardiogenic Shock: Should IABP or PVADs Be Used in Cardiogenic Shock?

American Heart & Vascular Institute

M. Ansari